Holen Sie sich die Stockscreener-App
4.04
4.94%
-0.21
Vorhandelsmarkt:
3.91
-0.13
-3.22%
Schlusskurs vom Vortag:
$4.25
Offen:
$4.21
24-Stunden-Volumen:
68,387
Relative Volume:
0.04
Marktkapitalisierung:
$6.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.22%
1M Leistung:
-7.13%
6M Leistung:
+269.96%
1J Leistung:
+95.74%
1-Tages-Spanne:
$3.93
$4.3032
1-Wochen-Bereich:
$3.7801
$4.5677
52-Wochen-Spanne:
$0.9693
$5.84
Entero Therapeutics Inc Stock (ENTO) Company Profile
Firmenname
Entero Therapeutics Inc
Sektor
Branche
Telefon
561-589-7020
Adresse
777 YAMATO ROAD, BOCA RATON
Vergleichen Sie ENTO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENTO
Entero Therapeutics Inc
|
4.04 | 9.02M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Entero Therapeutics Inc Aktie (ENTO) Neueste Nachrichten
Will Entero Therapeutics Inc. bounce back from current support2025 Technical Overview & Technical Pattern Based Signals - newser.com
Entero Regains Nasdaq Compliance With Grid AI Acquisition - Waynesboro Record Herald
Institutional scanner results for Entero Therapeutics Inc.2025 Retail Activity & Verified Entry Point Signals - newser.com
Using data filters to optimize entry into Entero Therapeutics Inc.Market Performance Report & Precise Buy Zone Tips - newser.com
Why Entero Therapeutics Inc. stock remains a top recommendation2025 Year in Review & Real-Time Volume Analysis Alerts - newser.com
Comparing Entero Therapeutics Inc. in custom built stock radarsFed Meeting & Weekly Return Optimization Plans - newser.com
Entero Therapeutics Inc. stock retracement – recovery analysisWeekly Volume Report & Community Shared Stock Ideas - newser.com
Will Entero Therapeutics Inc. stock recover after recent dropPortfolio Return Report & Low Risk High Reward Trade Ideas - newser.com
Entero Therapeutics Inc Stock Analysis and ForecastCandlestick Trading Patterns & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Using economic indicators to assess Entero Therapeutics Inc. potential2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - newser.com
Short interest data insights for Entero Therapeutics Inc.Weekly Stock Summary & Smart Money Movement Alerts - newser.com
Entero Therapeutics Regains Nasdaq Compliance After Extension - The Globe and Mail
Entero Therapeutics Regains Nasdaq Compliance - TradingView
Nasdaq confirms ENTO equity-rule compliance; next filing crucial - Stock Titan
Published on: 2025-10-31 04:45:42 - newser.com
Why analysts remain bullish on Entero Therapeutics Inc. stockSwing Trade & Advanced Technical Analysis Signals - newser.com
Published on: 2025-10-31 00:01:01 - newser.com
Grid AI Corp. completed the acquisition of Entero Therapeutics, Inc. in a reverse merger transaction. - MarketScreener
Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO) - ACCESS Newswire
Entero (NASDAQ: ENTO) acquires GRID AI, adds $50M+ grid tech and Nasdaq compliance - Stock Titan
Entero Therapeutics (NASDAQ: ENTO) acquires 100% of Grid AI, regains Nasdaq compliance - Stock Titan
Published on: 2025-10-29 01:24:51 - fcp.pa.gov.br
Why Entero Therapeutics Inc. stock is favored by top institutionsJuly 2025 Chart Watch & Advanced Technical Signal Analysis - fcp.pa.gov.br
Will Entero Therapeutics Inc. stock maintain dividend yieldJuly 2025 Update & Consistent Profit Trade Alerts - fcp.pa.gov.br
Finanzdaten der Entero Therapeutics Inc-Aktie (ENTO)
Es liegen keine Finanzdaten für Entero Therapeutics Inc (ENTO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):